| scholarly article | Q13442814 |
| P2093 | author name string | Davide Ricci | |
| Henry D Tazelaar | |||
| Christopher G A McGregor | |||
| Guerard W Byrne | |||
| Paul G Stalboerger | |||
| Naoto Miyagi | |||
| Zeji Du | |||
| Elise A Oehler | |||
| P2860 | cites work | Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage | Q72989924 |
| Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen | Q73045839 | ||
| Acute vascular rejection | Q77313011 | ||
| Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes | Q79532880 | ||
| Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience | Q81199195 | ||
| Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival | Q28210539 | ||
| Antigraft antibody-mediated expression of metalloproteinases on endothelial cells. Differential expression of TIMP-1 and ADAM-10 depends on antibody specificity and isotype. | Q32069292 | ||
| Rejection of cardiac xenografts transplanted from alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons | Q33718060 | ||
| Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation | Q33759347 | ||
| Potential use of genetically modified pigs as organ donors for transplantation into humans | Q33811447 | ||
| Production of alpha 1,3-galactosyltransferase-deficient pigs | Q33963251 | ||
| The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients | Q34055520 | ||
| Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors | Q34608583 | ||
| Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons | Q36691036 | ||
| The vascular and coagulation issues in xenotransplantation | Q37495795 | ||
| Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells | Q38299548 | ||
| Changes in cardiac gene expression after pig-to-primate orthotopic xenotransplantation | Q42691617 | ||
| Comparison of Gal and non-Gal-mediated cardiac xenograft rejection | Q42746065 | ||
| Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation | Q43239968 | ||
| Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function | Q46427137 | ||
| Cardiac xenotransplantation: recent preclinical progress with 3-month median survival | Q46695733 | ||
| Preformed antibodies to alpha1,3-galactosyltransferase gene-knockout (GT-KO) pig cells in humans, baboons, and monkeys: implications for xenotransplantation | Q46812792 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | xenograft | Q64148587 |
| P304 | page(s) | 686-692 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts | |
| P478 | volume | 93 |
| Q33752292 | Anti-non-Gal-specific combination treatment with an anti-idiotypic Ab and an inhibitory small molecule mitigates the xenoantibody response. |
| Q90214474 | Antigenicity of tissues and organs from GGTA1/CMAH/β4GalNT2 triple gene knockout pigs |
| Q56890337 | B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy |
| Q64900187 | B4GALNT2 and xenotransplantation: A newly appreciated xenogeneic antigen. |
| Q35012361 | Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons |
| Q34674815 | Cloning and expression of porcine β1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen |
| Q34376068 | Control of IBMIR in neonatal porcine islet xenotransplantation in baboons |
| Q36386394 | Current status of pig heart xenotransplantation |
| Q34674677 | Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cells |
| Q34185181 | Double transgenic pigs with combined expression of human α1,2-fucosyltransferase and α-galactosidase designed to avoid hyperacute xenograft rejection |
| Q37519520 | Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein. |
| Q47670138 | Effect of TNF-alpha blockade on coagulopathy and endothelial cell activation in xenoperfused porcine kidneys |
| Q37050158 | Efficient production of multi-modified pigs for xenotransplantation by 'combineering', gene stacking and gene editing |
| Q47643792 | Encouraging experience using multi-transgenic xenografts in a pig-to-baboon cardiac xenotransplantation model. |
| Q88059174 | Examining the Biosynthesis and Xenoantigenicity of Class II Swine Leukocyte Antigen Proteins |
| Q45994592 | First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprosthesis (by Naso et al.). |
| Q90529783 | Generation by somatic cell nuclear transfer of GGTA1 knockout pigs expressing soluble human TNFRI-Fc and human HO-1 |
| Q34018912 | Histopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejection |
| Q28081993 | Immunobiological barriers to xenotransplantation |
| Q33440243 | Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts. |
| Q36828449 | Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs |
| Q93227584 | Is Transgenic Porcine Skin as Good as Allogeneic Skin for Regenerative Medicine? Comparison of Chosen Properties of Xeno- and Allogeneic Material |
| Q26822638 | Kidney xenotransplantation |
| Q48132200 | Low anti-pig antibody levels are key to the success of solid organ xenotransplantation: But is this sufficient? |
| Q37361071 | Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study. |
| Q38121442 | New concepts of immune modulation in xenotransplantation. |
| Q91681745 | Perspectives on the Optimal Genetically Engineered Pig in 2018 for Initial Clinical Trials of Kidney or Heart Xenotransplantation |
| Q47136558 | Porcine to Human Heart Transplantation: Is Clinical Application Now Appropriate? |
| Q34250530 | Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literature |
| Q42569417 | Recent advances in understanding xenotransplantation: implications for the clinic |
| Q36386185 | Recent investigations into pig antigen and anti-pig antibody expression |
| Q34020948 | Rhesus monkeys and baboons develop clotting factor VIII inhibitors in response to porcine endothelial cells or islets |
| Q38878173 | Silencing porcine genes significantly reduces human-anti-pig cytotoxicity profiles: an alternative to direct complement regulation |
| Q50522196 | Suppression of Delayed Xenograft Rejection by Resveratrol in a Hamster-to-Rat Cardiac Transplantation Model. |
| Q94464392 | The Possible Role of Anti-Neu5Gc as an Obstacle in Xenotransplantation |
| Q91592665 | The complex functioning of the complement system in xenotransplantation |
| Q38712532 | The pathobiology of pig-to-primate xenotransplantation: a historical review |
| Q38013049 | The role of complement in the early immune response to transplantation. |
| Q34044894 | The role of genetically engineered pigs in xenotransplantation research |
| Q35124649 | Xenoantibody response to porcine islet cell transplantation using GTKO, CD55, CD59, and fucosyltransferase multiple transgenic donors |
| Q90496748 | Xenoantigen Deletion and Chemical Immunosuppression Can Prolong Renal Xenograft Survival |
| Q38019009 | Xenotransplantation literature update, March to April 2012. |
| Q89621137 | Xenotransplantation: Current Status in Preclinical Research |
| Q38187179 | Xenotransplantation: immunological hurdles and progress toward tolerance |
Search more.